Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes
Type 1 diabetes (T1D) is an organ-specific disease characterized by the deficiency of insulin caused by the autoimmune destruction of pancreatic islet β cells. Stem cell-based therapies play essential roles
Throne Welcomes Renowned Endocrinologist and Scientist, Dr. Theodore Mazzone, as Chief Medical Officer
Here at Throne Biotechnologies, we are pleased to announce Dr. Theodore Mazzone, M.D., as our new chief medical officer. Dr. Mazzone has been a clinical physician, scientist, and professor for nearly
New Molecular Mechanism for Stem Cell Educator Therapy: Suppression of B-Cell Activation by Cord Blood-Derived Stem Cells (CB-SC) via Galectin-9-Dependent Cell Contact Mechanism
Over the last 10 years, CB-SC have been utilized in international multicenter clinical trials and designated to Stem Cell Educatorâ (SCE) therapy for the treatment of autoimmune disease including type
Throne’s Crowd Funding Campaign at StartEngine Achieved beyond Our Expectations
We are happy to announce that Throne’s Equity Crowdfunding Campaign was closed yesterday, successfully raising more than enough money to kickstart our Clinical Trials at Throne Biotechnologies (Throne). We sincerely